Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Small Cell × belotecan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 3 Uterine Cervical Neoplasms 1 Lung Neoplasms 1 Carcinoma, Small Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 7 Etoposide 5 Pemetrexed 4 pembrolizumab 3 Topotecan 3 Gemcitabine 3 Carboplatin 3 belinostat 2 RRx-001 2 Paclitaxel 2 vosaroxin 1 vinflunine 1 veliparib 1 taxane 1 sagopilone 1 sacituzumab govitecan 1 pomalidomide 1 lurtotecan 1 liposomal doxorubicin 1 etoposide phosphate 1 enzalutamide 1 bemiparin 1 belotecan 1 apalutamide 1 alvocidib 1 abiraterone 1 Vinorelbine 1 Taxes 1 Sorafenib 1 Rhenium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00826644 2021-08-09

COMBAT

Chonnam National University Hospital

Phase 3 Completed

Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡